Related Experiment Video
Updated: Jan 21, 2026
09:39
DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat VNTR - Fragment Length Analysis FLA
Published on: July 15, 2011
27.8K
Intrapartum leprosy
Madeline Smoot1, Randy Volkmer1, Casey Roth2
1Texas A&M College of MedicineDallasTexas.
Proceedings (Baylor University. Medical Center)
|August 7, 2019
Summary
This case report discusses intrapartum leprosy, a rare condition caused by Mycobacterium leprae infection during pregnancy. It highlights a patient case and reviews current understanding of this third-trimester complication.
Area of Science:
- Microbiology
- Immunology
- Obstetrics
Background:
- Leprosy is caused by Mycobacterium leprae, an intracellular bacillus.
- Intrapartum leprosy typically manifests in the third trimester of pregnancy.
- Reduced cellular immunity during pregnancy may facilitate Mycobacterium leprae proliferation.
Observation:
- This case report details a patient presenting with active intrapartum leprosy.
- The patient was 32 weeks gestation at the time of presentation.
- The report reviews the current understanding of intrapartum leprosy.
Findings:
- Intrapartum leprosy is a rare complication of Mycobacterium leprae infection.
- Pregnancy-induced immunosuppression is a potential factor in disease onset.
- Early identification and management are crucial for maternal and fetal outcomes.
Implications:
- This case underscores the importance of recognizing leprosy in pregnant individuals.
- Further research is needed to understand the pathogenesis and optimal treatment of intrapartum leprosy.
- Improved diagnostic and therapeutic strategies are essential for managing leprosy during pregnancy.